| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100016207 Methods and Compositions for Raising Levels and Release of Gamma Aminobutyric Acid |
| 01/21/2010 | US20100015259 Composition and method for improving human concentration, memory and other cognitive brain |
| 01/21/2010 | US20100015229 Pharmaceutical compositions |
| 01/21/2010 | US20100015220 Niacin and nsaid combination therapy |
| 01/21/2010 | US20100015219 Pharmaceutical compositions of active substances difficult to improperly divert from their intended route of administration |
| 01/21/2010 | US20100015213 Compositions and Methods Using Same for Delivering Agents Into a Target Organ Protected by a Blood Barrier |
| 01/21/2010 | US20100015196 Drug Depot Implantable Within a Joint |
| 01/21/2010 | US20100015183 Transmucosal delivery devices with enhanced uptake |
| 01/21/2010 | US20100015178 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/21/2010 | US20100015165 Two Step Miniemulsion Process |
| 01/21/2010 | US20100015155 Pegylated abeta fab |
| 01/21/2010 | US20100015150 Tdf-related compounds and analogs thereof |
| 01/21/2010 | US20100015147 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside |
| 01/21/2010 | US20100015131 Composition Comprising Antibodies to LINGO or Fragments Thereof |
| 01/21/2010 | US20100015130 Disc-1 pathway activators in the control of neurogenesis |
| 01/21/2010 | US20100015117 Compositions and methods for targeting a polypeptide to the central nervous system |
| 01/21/2010 | US20100015105 Method of treating schizophrenia |
| 01/21/2010 | US20100015099 Materials and methods relating to treatment of injury and disease to the central nervous system |
| 01/21/2010 | CA2731215A1 Imidazole carboxamide derivatives and their use in treatment of conditions associated with the mglur2 receptor |
| 01/21/2010 | CA2731196A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
| 01/21/2010 | CA2730964A1 Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors |
| 01/21/2010 | CA2730959A1 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | CA2730929A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | CA2730843A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | CA2730793A1 Azole compound |
| 01/21/2010 | CA2730674A1 Treatment of inflammatory diseases with mammal beta defensins |
| 01/21/2010 | CA2730596A1 Stigmine conjugates for substance use disorders |
| 01/21/2010 | CA2730331A1 Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 01/21/2010 | CA2730287A1 Pharmaceutical formulations containing dopamine receptor ligands |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2729909A1 Imidazolyl pyrimidine inhibitor compounds |
| 01/21/2010 | CA2729606A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | CA2729597A1 Method of treating traumatic brain injury |
| 01/21/2010 | CA2728915A1 Benzyloxy anilide derivatives useful as potassium channel modulators |
| 01/21/2010 | CA2728636A1 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents |
| 01/21/2010 | CA2728562A1 Methods for treating multiple sclerosis using antisense oligonucleotides |
| 01/21/2010 | CA2720538A1 Solid states of o-desmethylvenlafaxine salts |
| 01/20/2010 | EP2145897A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/20/2010 | EP2145889A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 01/20/2010 | EP2145627A1 Use of uridine in combination with choline for the treatment of memory disorders |
| 01/20/2010 | EP2145622A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 01/20/2010 | EP2145620A2 Gaboxadol for treating depression and other affective disorders |
| 01/20/2010 | EP2144905A1 Therapeutic agents |
| 01/20/2010 | EP2144883A1 Crystalline forms i and ii of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine |
| 01/20/2010 | EP2144616A2 Use of hyperbaric conditions to provide neuroprotection |
| 01/20/2010 | EP2144614A1 Methods for treating spinal muscular atrophy using tetracycline compounds |
| 01/20/2010 | EP2144603A1 Use of a monoterpene to treat or prevent stress |
| 01/20/2010 | EP2144506A1 3-substituted-ý1,2,3¨-benzotriazinone compound for enhancing glutamatergic synaptic responses |
| 01/20/2010 | EP2144503A1 Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists |
| 01/20/2010 | EP1828179B1 Nicotinic alpha-7 receptor ligands against cns-related diseases |
| 01/20/2010 | EP1805141B1 Piperidines and related compounds for treatment of alzheimer's disease |
| 01/20/2010 | EP1611893B1 Remedy for nerve damage |
| 01/20/2010 | EP1458679B1 Pyrrolidine derivatives as prostaglandin modulators |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1418951B1 Transdermal therapeutic system (tts) with fentanyl as active ingredient |
| 01/20/2010 | EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 01/20/2010 | EP1059940B1 topical compositions comprising an alpha 1-adrenergic blocker FOR TREATING PAINFUL CONDITIONS OF THE ANAL REGION |
| 01/20/2010 | CN201384713Y Piperazine ferulate enteric-coated tablet |
| 01/20/2010 | CN101628905A C-aryl glucoside SGLT2 inhibitors and method |
| 01/20/2010 | CN101627974A Once-a-day oxycodone formulations |
| 01/20/2010 | CN100582233C Method for preparing krev alcohol and use for preparing anti-acetylcholinesterase medicine |
| 01/20/2010 | CN100582104C Oxadiazolone derivatives as PPAR delta agonists |
| 01/20/2010 | CN100582093C Hydroisoindoline tachykinin receptor antagonists |
| 01/20/2010 | CN100582087C 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581621C CNS chloride modulation and uses thereof |
| 01/20/2010 | CN100581586C A rapid-acting pharmaceutical composition |
| 01/20/2010 | CN100581578C Chinese traditional medicine capsule for healing neuropathic pain and preparing process technique thereof |
| 01/20/2010 | CN100581571C Chinese herbal medicine preparations for treating cerebral pasly through immersion |
| 01/20/2010 | CN100581562C Preparation method for separating and purifying extractive from lotus leaves, and usage |
| 01/20/2010 | CN100581551C Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS) |
| 01/20/2010 | CN100581550C Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 01/20/2010 | CN100581542C Use of rotigotine for preparing medicine for treating and preventing parkinson's plus syndrome |
| 01/19/2010 | US7649097 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649088 Diagnosis and treatment of Hereditary Spastic Paraplegia |
| 01/19/2010 | US7649020 treatment of sleep disorders and related diseases, with five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; preparing a new solvate of modafinil comprising dissolving in solvent and crystallizing |
| 01/19/2010 | US7649017 Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same |
| 01/19/2010 | US7649005 Substituted benzylaminoalkylene heterocycles |
| 01/19/2010 | US7648999 Activator for peroxisome proliferator-activated receptor δ |
| 01/19/2010 | US7648990 Chemical compounds |
| 01/19/2010 | US7648988 6-Chloro-2-piperazino-4-pyrrolidinopteridine derivatives; brain, nervous system, respiratory system, gastrointestinal, and psychological disorders; arthritis, antiasthmatics, cancer, leukemia, pain; Crohn's, Alzheimer's, and Parkinson's disease; multiple sclerosis; joint, eye and skin disorders |
| 01/19/2010 | US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
| 01/19/2010 | US7648983 Inhibits beta -secretase or beta -site amyloid precursor protein-cleaving enzyme (BACE); Alzheimer's disease; S)-4-(2,4-difluoro-5-(pyrimidin-5-yl)phenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine |
| 01/19/2010 | US7648978 Modulates hepatocyte growth factor (HGF); fibrotic liver disease, hepatic ischemia-reperfusion injury, cerebral infarction, ischemic heart disease, renal disease or lung (pulmonary) fibrosis, multiple sclerosis; 4-[4-(1-homopiperidinyl)phenyl]-1-(2H)-phthalazinone |
| 01/19/2010 | US7648706 West nile DNA vaccine |
| 01/19/2010 | US7648705 Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine |
| 01/19/2010 | CA2551157C Novel kappa receptor selective opioid peptides |
| 01/19/2010 | CA2420026C 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 01/19/2010 | CA2402751C Decahydro-isoquinolines |
| 01/19/2010 | CA2393466C Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2319640C Electrochemically reactive cathodes for an electrotransport device |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/14/2010 | WO2010006267A2 Cyclic tetrapeptides |
| 01/14/2010 | WO2010006103A1 Method for enhancing cognition or inhibiting cognitive decline |
| 01/14/2010 | WO2010005958A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | WO2010005581A1 Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of alzheimer's disease (ad) |
| 01/14/2010 | WO2010005580A2 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |